Condition: Headache (Migraine) · Migraine · Migraine Headache · Sponsor: Hospital Universitari Vall d'Hebron Research Institute
Patients will be asked to visit the study center 2 times, the first time for clinical assessment and a second time for sample collection. Healthy controls will only be asked to visit the study center for sample collection. A sample of blood and saliva will be collected in order to measure CGRP levels and DNA and hormone testing.
This description comes directly from the study's public registry record.
Patricia Pozo-Rosich, MD, PhD · (+34)934893000 · ppozo@vhebron.net
Always discuss trial participation with your own doctor first.
| Vall d'Hebron University Hospital | Barcelona, Barcelona, Spain | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06674772